Ignite Creation Date:
2025-12-24 @ 5:10 PM
Ignite Modification Date:
2025-12-25 @ 2:47 PM
Study NCT ID:
NCT00180050
Status:
COMPLETED
Last Update Posted:
2010-03-30
First Post:
2005-09-09
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Budesonide Treatment for Lymphocytic Colitis
Sponsor:
Technische Universität Dresden
Organization:
Study Overview
Official Title:
Efficacy and Safety of Budesonide for Treatment of Lymphocytic Colitis
Status:
COMPLETED
Status Verified Date:
2010-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine whether orale budesonide is effective in the treatment of lymphocytic colitis
Detailed Description:
The purpose of this study is to determine whether orale budesonide is effective in the treatment of lymphocytic colitis
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: